ES8401135A1 - Procedimiento de preparacion de proteoglicanos membranarios bacterianos. - Google Patents

Procedimiento de preparacion de proteoglicanos membranarios bacterianos.

Info

Publication number
ES8401135A1
ES8401135A1 ES520349A ES520349A ES8401135A1 ES 8401135 A1 ES8401135 A1 ES 8401135A1 ES 520349 A ES520349 A ES 520349A ES 520349 A ES520349 A ES 520349A ES 8401135 A1 ES8401135 A1 ES 8401135A1
Authority
ES
Spain
Prior art keywords
proteoglycans
medicine containing
membranous
interferon inducing
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES520349A
Other languages
English (en)
Other versions
ES520349A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9271781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8401135(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Publication of ES8401135A1 publication Critical patent/ES8401135A1/es
Publication of ES520349A0 publication Critical patent/ES520349A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26—Klebsiella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE PROTEOGLICANOS MEMBRANARIOS BACTERIANOS.CONSISTE EN TRATAR LOS PROTEOGLICANOS MEMBRANARIOS, A PARTIR DE UNA CEPA GRAM NEGATIVA KLEBSIELLA PNEUMONIAE, CON SOLUCION ACUOSA DE HIPOBROMITO, HIDROLIZANDO CON LISONZIMA LOS ENLACES N-ACETILMURAMIL-B-(1-4)-N-ACETILGLUCOSAMINA Y REDUCIENDO ASI EL PESO MOLECULAR DE ESTAS FRACCIONES. LA DURACION DE ESTA HIDROLISIS ESTA COMPRENDIDA ENTRE 10 MINUTOS Y UNA HORA. LOS PROTEOGLICANOS SON SEPARADOS POR CROMATOGRAFIA SOBRE UN GEL SEPHAROSA CL2B, OBTENIENDOSE ESTOS CON UN PESO MOLECULAR COMPRENDIDO ENTRE200.000 Y 400.000.
ES520349A 1982-03-09 1983-03-07 Procedimiento de preparacion de proteoglicanos membranarios bacterianos. Granted ES520349A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8203921A FR2523154A1 (fr) 1982-03-09 1982-03-09 Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant

Publications (2)

Publication Number Publication Date
ES8401135A1 true ES8401135A1 (es) 1983-12-16
ES520349A0 ES520349A0 (es) 1983-12-16

Family

ID=9271781

Family Applications (1)

Application Number Title Priority Date Filing Date
ES520349A Granted ES520349A0 (es) 1982-03-09 1983-03-07 Procedimiento de preparacion de proteoglicanos membranarios bacterianos.

Country Status (8)

Country Link
US (1) US4501693A (es)
EP (1) EP0089266B2 (es)
JP (1) JPS58164514A (es)
AT (1) ATE13911T1 (es)
CA (1) CA1197801A (es)
DE (1) DE3360289D1 (es)
ES (1) ES520349A0 (es)
FR (1) FR2523154A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2540136A1 (fr) * 1983-01-28 1984-08-03 Roussel Uclaf Nouveau procede de preparation d'acylglycoproteines immunostimulantes extraites de klebsiella pneumoniae, compositions pharmaceutiques et procede de lutte contre les maladies allergiques
FR2570081B1 (fr) * 1984-09-10 1987-01-09 Pf Medicament Polysaccharides membranaires utiles notamment comme medicament et procede pour leur preparation
FR2574429B1 (fr) * 1984-12-06 1987-12-11 Roussel Uclaf Acylglycannes extraits de klebsiella, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2598434B1 (fr) * 1986-05-12 1988-09-16 Pf Medicament Nouveaux immunomodulateurs obtenus par hemisynthese a partir d'un polysaccharide bacterien isole d'une souche mutante non capsulee de klebsiella pneumoniae
FR2614306B1 (fr) * 1987-04-22 1989-07-28 Pf Medicament Nouveau derive de d.25, procede de preparation, utilisation a titre d'agent immunostimulant et compositions pharmaceutiques le contenant.
FR2650506B1 (fr) * 1989-07-11 1991-11-08 Roussel Uclaf Galactanne extrait de klebsiella, procede d'obtention et application a titre de medicament
CH680192A5 (es) * 1989-12-13 1992-07-15 Nestle Sa
DE4308443C2 (de) * 1993-03-17 1996-09-19 Laves Hans Georg Arzneimittel zur Behandlung von Retrovirusinfektionen
FR2790960B1 (fr) * 1999-03-15 2002-10-31 Pf Medicament Utilisation de fractions membranaires bacteriennes a activite immunostimulante dans le traitement de cancers, leurs procedes de preparation et les compositions pharmaceutiques les contenant
GB0006333D0 (en) 2000-03-16 2000-05-03 Raychem Ltd Electrical wire insulation
EP3927356A2 (en) * 2019-02-22 2021-12-29 Evelo Biosciences, Inc. Bacterial membrane preparations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855197A (en) * 1969-05-20 1974-12-17 Cassenne Lab Sa Glycoproteins extracted from microorganisms
FR2088112B2 (es) * 1970-05-20 1975-01-10 Cassenne Lab Sa
FR2160326B1 (es) * 1971-11-19 1975-02-07 Anvar
BE795417A (fr) * 1972-02-15 1973-08-14 Roussel Uclaf Nouveaux composes d'origine-bacterienne et procede d'obtention
US3976544A (en) * 1973-06-19 1976-08-24 The Agence Nationale De Valorisation De Le Recherche Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
FR2248025A2 (en) * 1973-10-23 1975-05-16 Anvar Vaccine compsns. - contg. N-acyl muramic acid deriv. as adjuvant
FR2315945A1 (fr) * 1975-07-03 1977-01-28 Cassenne Lab Sa Nouvelles glycoproteines isolees d'aerobacter cloacae, procede de preparation et application a titre de medicaments de ces produits
FR2405298A1 (fr) * 1977-01-27 1979-05-04 Cassenne Lab Sa Nouvelles glycoproteines isolees d'escherichia coli, procede de preparation et application de medicaments
FR2378855A1 (fr) * 1977-01-27 1978-08-25 Cassenne Lab Sa Nouvelles glycoproteines isolees d'hafnia, procede de preparation et application a titre de medicaments
FR2444464A1 (fr) * 1978-12-19 1980-07-18 Fabre Sa Pierre Proteoglycanes bacteriens purifies, procede pour leur preparation et vaccin les contenant
FR2490495A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines hydrosolubles immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
US4451446A (en) * 1982-03-04 1984-05-29 Smithkline-Rit Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them

Also Published As

Publication number Publication date
DE3360289D1 (en) 1985-07-25
EP0089266B1 (fr) 1985-06-19
ATE13911T1 (de) 1985-07-15
CA1197801A (fr) 1985-12-10
US4501693A (en) 1985-02-26
FR2523154B1 (es) 1984-12-14
JPS58164514A (ja) 1983-09-29
FR2523154A1 (fr) 1983-09-16
JPH0587519B2 (es) 1993-12-16
ES520349A0 (es) 1983-12-16
EP0089266A1 (fr) 1983-09-21
EP0089266B2 (fr) 1989-08-30

Similar Documents

Publication Publication Date Title
ES8401135A1 (es) Procedimiento de preparacion de proteoglicanos membranarios bacterianos.
MX9708438A (es) Proteina principal de la membrana externa de moraxella, de alto peso molecular.
IT8349510A0 (it) Procedimento per la produzione di acido ialuronico da colture batteriche
ES8403724A1 (es) Un procedimiento para preparar un complejo inmunogeno no covalentes de polisacarido-proteina, y obtenido a partir de capsulas bacterianas.
ZA891662B (en) Antibiotic
AU8331082A (en) Vaccines
GB1508050A (en) Bovine milk products
NZ209128A (en) Method of externalising bacterial products
HUT50048A (en) Process for producing streptococcus protein antigen and pharmaceutical compositions comprising same
AU8314587A (en) New oligosaccharides, immunogens and vaccines, and methods for preparing such oligosaccharides, immunogens and vaccines
DE2963201D1 (en) Purified bacterial proteoglycans, process for their preparation and vaccine containing them
ES8406850A1 (es) Metodo de preparar productos lacteos en polvo
ES414021A1 (es) Procedimiento para el aislamiento de la beta1-glicoproteina-fa (fase agua) y la alfa2-glicoproteina-fa.
JPS5782322A (en) Novel immunostimulant sugar protein extracted from pneumonia bacillus,obtaining method, application as drug and composition containing same
ES469225A1 (es) Procedimiento para potenciar la accion de las vacunas.
DE2964176D1 (en) Heteropolysaccharides produced by bacteria and derived products, their preparation, and the lyophilized culture of the bacteria
CA2030951A1 (en) Process for producing immunostimulant agents
FR2384779A1 (fr) Nouvelles oximes derivees de l'acide 3-chloro ou 3-methoxy 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
JPS5782321A (en) Novel water-soluble immunostimulant sugar protein extracted from pneumonia bacillus, obtaining method,application as drug and composition containing same
JPS5781415A (en) Single strain vaccine for infectious disease by some strains of cilia bacteria
EP0301718A3 (en) Process for preparing novel diamines
JPS645488A (en) Novel d-aminoacylase and production thereof
UA5567A1 (uk) Спосіб отримання d-l-амінокислот
JPS6171B2 (es)
DE3363975D1 (en) Polysaccharide substance, process for the production of same, pharmaceutical compositions containing the same and their use as medicaments

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19981001